CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+22.53%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$295M
AUM Growth
+$46.7M
(+19%)
Cap. Flow
+$10.2M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| 1 |
NVIDIA
NVDA
|
$7.81M |
| 2 |
PayPal
PYPL
|
$4.77M |
| 3 |
STAAR Surgical
STAA
|
$3.64M |
| 4 |
Chipotle Mexican Grill
CMG
|
$3.46M |
| 5 |
Microsoft
MSFT
|
$3.33M |
Top Sells
| 1 |
iQIYI
IQ
|
$7.64M |
| 2 |
Pinduoduo
PDD
|
$6.59M |
| 3 |
ON Semiconductor
ON
|
$4.45M |
| 4 |
Apple
AAPL
|
$3.07M |
| 5 |
Rambus
RMBS
|
$2.77M |
Sector Composition
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Amphastar Pharmaceuticals
AMPH
$1.37B
| $24.6K | 0.01% |
655
+164
| +33% | +$6.15K |
|
202
Akero Therapeutics
AKRO
$3.58B
| $24.3K | 0.01% |
634
+159
| +33% | +$6.08K |
|
203
Genmab
GMAB
$16.9B
| $23.9K | 0.01% |
632
+198
| +46% | +$7.48K |
|
204
FibroGen
FGEN
$48.9M
| $23.8K | 0.01% |
51
+13
| +34% | +$6.07K |
|
205
Xencor
XNCR
$610M
| $22.7K | 0.01% |
814
+205
| +34% | +$5.72K |
|
206
Kymera Therapeutics
KYMR
$3.11B
| $22.2K | 0.01% |
748
+191
| +34% | +$5.66K |
|
207
Ironwood Pharmaceuticals
IRWD
$188M
| $22K | 0.01% |
2,089
+531
| +34% | +$5.59K |
|
|
SWTX
208
DELISTED
SpringWorks Therapeutics
SWTX
| $21.8K | 0.01% |
847
+213
| +34% | +$5.48K |
|
209
Lam Research
LRCX
$130B
| $21.7K | 0.01% |
+410
| New | +$21.7K |
|
210
Veracyte
VCYT
$2.55B
| $21.7K | 0.01% |
972
+243
| +33% | +$5.42K |
|
211
Fiserv
FI
$73.4B
| $21.5K | 0.01% |
+190
| New | +$21.5K |
|
212
BioCryst Pharmaceuticals
BCRX
$1.74B
| $21.3K | 0.01% |
2,554
+661
| +35% | +$5.51K |
|
213
Edwards Lifesciences
EW
$47.5B
| $21.2K | 0.01% |
256
| – | – |
|
214
Aurinia Pharmaceuticals
AUPH
$1.63B
| $21.2K | 0.01% |
1,932
+488
| +34% | +$5.35K |
|
215
CureVac
CVAC
$1.21B
| $21K | 0.01% |
3,008
+1,075
| +56% | +$7.49K |
|
|
KDNY
216
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $20.7K | 0.01% |
892
+243
| +37% | +$5.63K |
|
217
Pliant Therapeutics
PLRX
$114M
| $20.6K | 0.01% |
773
+278
| +56% | +$7.4K |
|
|
ATVI
218
DELISTED
Activision Blizzard Inc.
ATVI
| $20.3K | 0.01% |
+237
| New | +$20.3K |
|
|
MORF
219
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $20.2K | 0.01% |
536
+144
| +37% | +$5.42K |
|
220
Immunocore
IMCR
$1.87B
| $20K | 0.01% |
404
+142
| +54% | +$7.02K |
|
221
Micron Technology
MU
$147B
| $19.9K | 0.01% |
+330
| New | +$19.9K |
|
222
Arvinas
ARVN
$575M
| $19.7K | 0.01% |
722
+181
| +33% | +$4.95K |
|
223
Travere Therapeutics
TVTX
$1.93B
| $19.7K | 0.01% |
877
+225
| +35% | +$5.06K |
|
224
Syndax Pharmaceuticals
SNDX
$1.47B
| $19.6K | 0.01% |
928
+316
| +52% | +$6.67K |
|
225
CSX Corp
CSX
$60.6B
| $18.7K | 0.01% |
+624
| New | +$18.7K |
|